Join the Adderall XR group to help and get support from people like you.
Adderall XR News
ADHD Meds Tied to Heart Damage in Young Adult Users
WEDNESDAY, March 27, 2024 – ADHD stimulant medications like Ritalin or Adderall appear linked to a heightened risk for cardiomyopathy (a weakening of the heart muscle), and the risk grows with time,...
Taking 'Study Drugs' Like Adderall Could Be Gateway to More Drug Abuse
THURSDAY, March 14, 2024 – College students who use drugs like Adderall to help them focus on their studies may be setting themselves up for trouble. Researchers asked 700 undergraduates across the...
In Utero Rx Stimulant Exposure Not Tied to Later Neurodevelopmental Issues
THURSDAY, Feb. 1, 2024 --Amphetamine/dextroamphetamine and methylphenidate exposure in utero does not appear to increase the risk for childhood neurodevelopmental disorders, according to a study...
ADHD: What Parents Need to Know
MONDAY, Sept. 4, 2023 – Lots of children and adolescents have the condition known as ADHD, or attention-deficit/hyperactivity disorder. What should parents know? A number of treatments exist to help...
After U.S. Warns of Counterfeit Pills Laced With Fentanyl, Mexico Shuts Down 23 Pharmacies
WEDNESDAY, Aug. 9, 2023 – Following a four-day raid, Mexico has closed 23 pharmacies in Caribbean resorts of Cancun, Playa del Carmen and Tulum for irregular pill sales. Last spring, the United...
Taking ADHD Meds Won't Raise a Kid's Odds for Drug Abuse Later: Study
THURSDAY, July 6, 2023 – Stimulant medications like Ritalin are commonly prescribed to help treat the symptoms of attention deficit hyperactivity disorder, but there have been concerns the drugs may...
FDA Medwatch Alert: FDA Updating Warnings to Improve Safe Use of Prescription Stimulants Used to Treat ADHD and Other Conditions
What safety concern is FDA announcing? To address continuing concerns of misuse, abuse, addiction, and overdose of prescription stimulants, the U.S. Food and Drug Administration (FDA) is requiring...
FDA Approves Mydayis (mixed salts of a single-entity amphetamine product) – A New Once-Daily Option for ADHD
Lexington, Mass., USA – June 20, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) has approved Mydayis (mixed salts of a single-entity amp...
FDA Medwatch Alert: Teva's Adderall 30 mg Tablets: Counterfeit Product - Contains Wrong Active Ingredients
ISSUE: FDA is warning consumers and health care professionals about a counterfeit version of Teva Pharmaceutical Industries' Adderall 30 milligram tablets that is being purchased on the Internet....
FDA Medwatch Alert: Adderall XR (amphetamine)
FDA issued a Public Health Advisory to notify healthcare professionals that Health Canada, the Canadian drug regulatory agency, has suspended the sale of Adderall XR in the Canadian market. Adderall...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Attention-Deficit Hyperactivity Disorder (ADHD)